A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Myelination and remyelination are crucial for CNS function.
• Failure of oligodendrocyte progenitor cell (OPC) maturation leads to delayed myelination and impaired remyelination.
• Hyaluronan (HA) digestion products are implicated in inhibiting OPC maturation, but their source remains unclear.

Purpose of the Study:

• To investigate the role of hyaluronidase activity in OPC maturation.
• To develop and test a novel hyaluronidase inhibitor for promoting OPC maturation and remyelination.

Main Methods:

• Development of a modified flavonoid (S3) as a selective hyaluronidase inhibitor.
• In vitro studies assessing S3's effect on HA-mediated inhibition of OPC maturation.
• In vivo studies using a mouse model of demyelination to evaluate S3's impact on remyelination.

Main Results:

• S3 reversed HA-mediated inhibition of OPC maturation in vitro.
• Hyaluronidase inhibition by S3 accelerated OPC maturation in an in vitro model of perinatal white matter injury.
• S3 treatment promoted functional remyelination in mice with induced demyelinating lesions.

Conclusions:

• Hyaluronidase activity from OPCs in CNS lesions is sufficient to inhibit OPC maturation and block remyelination.
• Modified flavonoids like S3 are effective hyaluronidase inhibitors and can promote OPC maturation.
• S3 demonstrates potential as a therapeutic agent to accelerate myelination and promote remyelination in CNS disorders.